CREDIT SUISSE AG/ - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 21 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$11,000
-45.0%
10,121
-1.5%
0.00%–
Q1 2019$20,000–10,270–0.00%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q3 2019.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders